Category VIEW ALL
Splice-Switching Antisense Oligonucleotides for Treating NLRP3-mediated Inflammatory Disease
Technology No. 2024-540
Ultrasound Assisted Gene Therapy
Technology No. 2023-335
New Oral Immunotherapy Platform for the Treatment of Food Allergy and Other Autoimmune Diseases
Technology No. 2021-100
Immune Isolating Device With Improved Diffusion
Technology No. 2024-096
Design and Synthesis of Novel Retinoids
Technology No. 7453
Bioinspired Nanotherapeutics for Managing Periapical Bone Inflammation
Technology No. 2024-524
Bile Salt and Corticosteroid Microparticles for Controlled Release Drug Delivery Applications
Technology No. 2021-314
Biodegradable protein based Nanoparticles for drug delivery
Technology No. 2020-143
Hydrogel Guidance Tubes for Aligned Tissue Regeneration
Technology No. 7763
Use of 4-PBA for the Prevention and Treatment of Vascular Lesions in CM-AVM
Technology No. 2020-058
Tofacitinib for Treatment of Amyotrophic Lateral Sclerosis
Technology No. 2019-053
Use of Retinoids in Congenital Erythropoietic Porphyria
Technology No. 2022-276
Therapeutic Use of Carbamoyl Phosphate Synthatase-1
Technology No. 2019-076
Methods for the Treatment of Nicotine Dependence
Technology No. 2020-397
Pharmacotherapies for COVID-19
Technology No. 2020-487
Lactoferrin Inhibition of SARS-CoV-2 Viral Entry and Immunomodulatory Suppression of IL-6
Technology No. 2020-433
Selective Kinase Degraders (PROTACs) for Oncology
Technology No. 2022-262
Meta Anilide Inhibitors of MRTF
Technology No. 2021-316
HDAC6 Inhibitors to Treat Diabetes
Technology No. 2021-217
Composition for Monomer Ash1L Inhibitors and Method of Use Thereof
Technology No. 2019-153
Graves Eye Disease New Treatment
Technology No. 2018-321
Polygenic Markers of Hepatic Steatosis and Cirrhosis
Technology No. 2021-461
Modulating the Gut Microbiome to Treat Disease
Technology No. 2022-186
PRC1 Inhibitors
Technology No. 2018-372
Novel Small Molecules and Their Use as MALT1 Inhibitors
Technology No. 2021-126
Novel Structure-Based Rifamycins for Drug-Resistant TB and HIV Co-Infection
Technology No. 2021-114
ML355-sHDL as a New Delivery Mechanism for Antiplatelet Therapy Targeting 12-Lipoxygenase
Technology No. 2021-132
The Method to Give Bacteria Probiotic Features by Genetic Engineering
Technology No. 2021-103
Carbon Nanotubules for Delivery of the Ocular Drugs
Technology No. 2019-427
Photomediated Ultrasound Therapy Method and Apparatus
Technology No. 7785
2-Hydroxybenzoic Acid Derivatives as Inhibitors and Degraders of Sirtuins
Technology No. 2022-340
Modulation of Pyruvate Kinase M2 as a Therapeutic Strategy for Proliferative Vitreoretinopathy
Technology No. 2022-202
BanLec-CAR T Cells for Cancer Therapy
Technology No. 2019-123
Small-Molecule Inhibitors of DCN1
Technology No. 7301
Covalent Small-Molecule Inhibitors of DCN1 Protein
Technology No. 7456
ARlnc1 in Prostate Cancer Progression
Technology No. 7386
Lipids for Nucleic Acid Based Vaccines
Technology No. 2022-117
Dual-Function Lipidated NCEs
Technology No. 2022-116
Chlorophenyl Inhibitors of Glucosylceramide Synthase
Technology No. 2019-311
Pyridine Inhibitors of Glucosylceramide Synthase
Technology No. 2019-268
Synthetic High Density Lipoprotein for Treatment of Infections Complications
Technology No. 2020-434
A Small Molecular Compound for Arthritis and Bone Erosion Treatment
Technology No. 7656
New Oral Drug Strategy for Targeting Pancreas
Technology No. 2021-411
Gastrointestinal (GI) Locally-Activating JAK Inhibitor for Treatment of Ulcerative Colitis
Technology No. 2022-281
Targeting Oncogenic Transcriptional Programs Through Tissue Specificity
Technology No. 2021-208
Nanoemulsion Vaccine Induces Cross-Protection to Suppress Reactivity to Multiple Food Allergens
Technology No. 2021-194
BpV(pic) and Hair Growth
Technology No. 2021-308
IgA Induced Mucosal Immune Tolerance
Technology No. 2021-134
Novel Drug Formulation
Technology No. 2019-436
Role of Nanoemulsion Vaccine in Chronic Cockroach Allergic Asthma
Technology No. 2019-481
SGLT Inhibitor Drug for Treating Liver Diseases
Technology No. 2021-312
Combined Agonist Adjuvants for Vaccines
Technology No. 2021-322
Microbial Metabolites for Improving Cancer Immunotherapy
Technology No. 2021-483
PKC Inhibition to Allow Extended tPA Treatment for Stroke
Technology No. 7702
Updated Non-Invasive Cervical Cerclage
Technology No. 2021-392
Cancer Stem Cell Vaccination and Treatment
Technology No. 5486
Phase Correction for Single Pixel Camera in a Lissajous Pattern
Technology No. 2018-422
A Concentrated Form of Valproate to be Delivered via Bone for the Treatment of Hemorrhagic Shock
Technology No. 2019-471
Small Molecule Positive Modulators of Ligand-Induced Ret Signaling
Technology No. 2020-313
Mitochondrial Targeting Compounds for the Treatment of Associated Diseases
Technology No. 2020-134
Methods for Establishing Drug Supersaturation from a Porous Host
Technology No. 2019-069
Ear Implant for Reconstruction
Technology No. 7095
